Roivant Sciences ROIV
NASDAQ ROIV
$35.72 +0.22 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Change in Accured Expenses (2020 - 2026)

Updated

Roivant Sciences' Change in Accured Expenses came in at -$13.91 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$25 million a year earlier.

Analysis

Roivant Sciences (ROIV) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Roivant Sciences reported Change in Accured Expenses of $70.42 million; for FY2026 (ended Mar 31, 2026), it came in at $59.33 million.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 45.1% (FY2021 to FY2026).
  • Going back by fiscal year, Change in Accured Expenses was -$10.07 million in FY2025, $40.15 million in FY2024 (+3.1%), $38.96 million in FY2023 (-23.0%) and $50.6 million in FY2022 (+448.5%).
  • The five-year range for quarterly Change in Accured Expenses is -$49.96 million (fiscal Q1 2024) to $63.23 million (fiscal Q4 2026).
  • Year-over-year, Change in Accured Expenses increased in 1 of the last four quarters, with growth averaging 100.6%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in fiscal Q2 2022 (growth of 743.9%), and the weakest in fiscal Q4 2025 (a decline of 83.1%).
  • Business Quant data shows ROIV's Change in Accured Expenses at $63.23 million (Q4 2026), $8.58 million (Q3 2026) and $12.52 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Roivant Sciences 25.81 Bn 26.50 Bn 1.16 Mn -13.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.91 Mn
Mar 31, 2026 63.23 Mn
Dec 31, 2025 8.58 Mn
Sep 30, 2025 12.52 Mn
Jun 30, 2025 -25.00 Mn
Mar 31, 2025 9.44 Mn
Dec 31, 2024 -3.03 Mn
Sep 30, 2024 21.11 Mn
Jun 30, 2024 -37.58 Mn
Mar 31, 2024 55.94 Mn
Dec 31, 2023 -3.40 Mn
Sep 30, 2023 37.57 Mn
Jun 30, 2023 -49.96 Mn
Mar 31, 2023 33.25 Mn
Dec 31, 2022 4.26 Mn
Sep 30, 2022 19.62 Mn
Jun 30, 2022 -18.18 Mn
Mar 31, 2022 15.02 Mn
Dec 31, 2021 17.01 Mn
Sep 30, 2021 25.91 Mn
API Access

Roivant Sciences Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ROIV&period=max&api_key=YOUR_API_KEY